Skip to main content
Premium Trial:

Request an Annual Quote

D&MD Publications RNAi -- Broad Application, Expansive Opportunity Report

Premium

D&MD Publications has recently introduced a research report entitled “RNAi — Broad Application, Expansive Opportunity.”

According to D&MD, the report includes an analysis of trends in the RNAi technology market including strengths, weaknesses, and opportunities through extensive qualitative and quantitative research; overviews of current phase I clinical trials for RNAi-based therapeutics; and profiles of leading companies who develop therapeutics.

The report also discusses other RNA technologies use in target validation such as antisense, ribozymes, and aptamers.

The Scan

Fertility Fraud Found

Consumer genetic testing has uncovered cases of fertility fraud that are leading to lawsuits, according to USA Today.

Ties Between Vigorous Exercise, ALS in Genetically At-Risk People

Regular strenuous exercise could contribute to motor neuron disease development among those already at genetic risk, Sky News reports.

Test Warning

The Guardian writes that the US regulators have warned against using a rapid COVID-19 test that is a key part of mass testing in the UK.

Science Papers Examine Feedback Mechanism Affecting Xist, Continuous Health Monitoring for Precision Medicine

In Science this week: analysis of cis confinement of the X-inactive specific transcript, and more.